semaglutide cardiac FDA Clears For Risk Reduction in Diabetic Patients Insights into semaglutide cardiovascular research:

Description

Federal approval would allow Connecticut to partner with a generic drug maker to bring down costs

PlexusDx offers compounded semaglutide injection starting at $149 per month through licensed 503A compounding pharmacies, making modern GLP-1 therapy accessible without insurance

OASIS 4 & oral Wegovy approval: Novo Nordisk Dec 2025 press release / FDA

Washington We accept major insurance plans from: Virginia We accept major insurance plans from: Texas We accept major insurance plans from: Oregon We accept major insurance plans from: Ohio We accept major insurance plans from: North Carolina We accept major insurance plans from: New York We accept major insurance plans from: New Jersey We accept major insurance plans from: Michigan We accept major insurance plans from: Minnesota We accept major insurance plans from: Indiana We accept major insurance plans from: Kentucky We accept major insurance plans from: Illinois We accept major insurance plans from: Idaho We accept major insurance plans from: Hawaii We accept major insurance plans from: Georgia We accept major insurance plans from: California We accept major insurance plans from: Florida We accept major insurance plans from: Colorado We accept major insurance plans from: Arizona We accept major insurance plans from: States name goes here We're actively working to accept insurance in your state